Female sterilisation in the United States

Nikki Zite, Sonya Borrero

Research output: Contribution to journalReview article

17 Citations (Scopus)

Abstract

Female sterilisation is a safe and effective form of permanent birth control. In the United States (US), it is still the second most commonly used form of contraception overall and is the most frequently used method among married women and among women over 30 years of age. Although several European countries have noted a sharp decline in the number of women electing tubal sterilisation in recent years, such trends have not been as obvious in the US. While female sterilisation remains popular, there are considerable system-level barriers to getting the procedure for certain segments of the population as well as emerging concerns about appropriate utilisation of this contraceptive method in light of newer, reversible options and the knowledge that regret after permanent contraception is high. Given the complexity of this decision-making process, it is critical that providers ensure at the very least that women are aware of the potential disadvantages of tubal occlusion and are knowledgeable of other highly effective contraceptive methods that are available but vastly underutilised in the US, namely, vasectomy, intrauterine contraceptives, and implants.

Original languageEnglish (US)
Pages (from-to)336-340
Number of pages5
JournalEuropean Journal of Contraception and Reproductive Health Care
Volume16
Issue number5
DOIs
StatePublished - Oct 1 2011

Fingerprint

Reproductive Sterilization
Contraception
Tubal Sterilization
Vasectomy
Contraceptive Agents
Decision Making
Emotions
Population

All Science Journal Classification (ASJC) codes

  • Reproductive Medicine
  • Obstetrics and Gynecology
  • Pharmacology (medical)

Cite this

Female sterilisation in the United States. / Zite, Nikki; Borrero, Sonya.

In: European Journal of Contraception and Reproductive Health Care, Vol. 16, No. 5, 01.10.2011, p. 336-340.

Research output: Contribution to journalReview article

@article{1fe935fa54e54e75babc4e2003275b61,
title = "Female sterilisation in the United States",
abstract = "Female sterilisation is a safe and effective form of permanent birth control. In the United States (US), it is still the second most commonly used form of contraception overall and is the most frequently used method among married women and among women over 30 years of age. Although several European countries have noted a sharp decline in the number of women electing tubal sterilisation in recent years, such trends have not been as obvious in the US. While female sterilisation remains popular, there are considerable system-level barriers to getting the procedure for certain segments of the population as well as emerging concerns about appropriate utilisation of this contraceptive method in light of newer, reversible options and the knowledge that regret after permanent contraception is high. Given the complexity of this decision-making process, it is critical that providers ensure at the very least that women are aware of the potential disadvantages of tubal occlusion and are knowledgeable of other highly effective contraceptive methods that are available but vastly underutilised in the US, namely, vasectomy, intrauterine contraceptives, and implants.",
author = "Nikki Zite and Sonya Borrero",
year = "2011",
month = "10",
day = "1",
doi = "10.3109/13625187.2011.604451",
language = "English (US)",
volume = "16",
pages = "336--340",
journal = "European Journal of Contraception and Reproductive Health Care",
issn = "1362-5187",
publisher = "Informa Healthcare",
number = "5",

}

TY - JOUR

T1 - Female sterilisation in the United States

AU - Zite, Nikki

AU - Borrero, Sonya

PY - 2011/10/1

Y1 - 2011/10/1

N2 - Female sterilisation is a safe and effective form of permanent birth control. In the United States (US), it is still the second most commonly used form of contraception overall and is the most frequently used method among married women and among women over 30 years of age. Although several European countries have noted a sharp decline in the number of women electing tubal sterilisation in recent years, such trends have not been as obvious in the US. While female sterilisation remains popular, there are considerable system-level barriers to getting the procedure for certain segments of the population as well as emerging concerns about appropriate utilisation of this contraceptive method in light of newer, reversible options and the knowledge that regret after permanent contraception is high. Given the complexity of this decision-making process, it is critical that providers ensure at the very least that women are aware of the potential disadvantages of tubal occlusion and are knowledgeable of other highly effective contraceptive methods that are available but vastly underutilised in the US, namely, vasectomy, intrauterine contraceptives, and implants.

AB - Female sterilisation is a safe and effective form of permanent birth control. In the United States (US), it is still the second most commonly used form of contraception overall and is the most frequently used method among married women and among women over 30 years of age. Although several European countries have noted a sharp decline in the number of women electing tubal sterilisation in recent years, such trends have not been as obvious in the US. While female sterilisation remains popular, there are considerable system-level barriers to getting the procedure for certain segments of the population as well as emerging concerns about appropriate utilisation of this contraceptive method in light of newer, reversible options and the knowledge that regret after permanent contraception is high. Given the complexity of this decision-making process, it is critical that providers ensure at the very least that women are aware of the potential disadvantages of tubal occlusion and are knowledgeable of other highly effective contraceptive methods that are available but vastly underutilised in the US, namely, vasectomy, intrauterine contraceptives, and implants.

UR - http://www.scopus.com/inward/record.url?scp=80052995312&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052995312&partnerID=8YFLogxK

U2 - 10.3109/13625187.2011.604451

DO - 10.3109/13625187.2011.604451

M3 - Review article

VL - 16

SP - 336

EP - 340

JO - European Journal of Contraception and Reproductive Health Care

JF - European Journal of Contraception and Reproductive Health Care

SN - 1362-5187

IS - 5

ER -